Consideration of cytokines as therapeutics agents or targets

Z Xing1, J Wang

  • 1Department of Pathology and Molecular Medicine, and Division of Infectious Diseases, Centre for Gene Therapeutics, McMaster University, Hamilton, Ontario, L8N 3Z5, Canada. xingz@fhs.mcmaster.ca

Insights

Cytokine biology has advanced significantly, leading to new disease treatments. This review explores cytokine properties, classifications, and therapeutic applications for various conditions, including inflammation, infections, and cancer.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Recent advances in cytokine biology have spurred the development of novel disease therapies.
  • Cytokines play dual roles as potential therapeutics and disease targets.

Purpose of the Study:

  • To provide an introductory overview of cytokine biology.
  • To serve as a guide to a thematic issue on cytokine therapeutic biology.
  • To cover key aspects of cytokine properties, classification, and therapeutic applications.

Main Methods:

  • Literature review and synthesis of current knowledge on cytokines.
  • Discussion of cytokine roles in health and disease.
  • Exploration of therapeutic strategies involving cytokines.

Main Results:

  • Detailed examination of general cytokine properties and classifications.
  • Analysis of human conditions linked to cytokine under-expression and over-expression.
  • Overview of the T helper 1 (Th1) and T helper 2 (Th2) paradigm.

Conclusions:

  • Cytokine knowledge is rapidly translating into clinical applications.
  • Cytokines offer potential for treating inflammatory conditions, infectious diseases, and cancer.
  • Understanding cytokine biology is crucial for advancing therapeutic strategies.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...